Showing cs.CLShow all
2 papers · 1 filter
cs.CL2025
GLiNER-BioMed: A Suite of Efficient Models for Open Biomedical Named Entity Recognition
Anthony Yazdani, Ihor Stepanov, Douglas Teodoro
Biomedical named entity recognition (NER) presents unique challenges due to specialized vocabularies, the sheer volume of entities, and the continuous emergence of novel entities.…
cs.CL2025
An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results
Anthony Yazdani, Alban Bornet, Philipp Khlebnikov +4
Adverse drug events (ADEs) are a major safety issue in clinical trials. Thus, predicting ADEs is key to developing safer medications and enhancing patient outcomes. To support this…